Lung Cancer Considered

Dr. Heather Wakelee thoracic medical oncologist and professor of medicine at Stanford University Medical Center and president-elect of IASLC and Corinne Faivre-Finn professor of thoracic radition oncology at the University of Manchester in the UK and honorary consultant clinical oncologist joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain to discuss women leader...

Dr. Tony Mok, Li Shu Fan Medical Foundation professor of clinical oncology in the department of Clinical Oncology at the Chinese University of Hong Kong, joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain discuss highlights and new research from the conference. Dr. Mok is a past president of IASLC.

Dr. Benjamin Solomon, lead investigator and medical oncologist at Peter MacCallum Cancer Centre, Melbourne, Australia joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain to discuss his journey to thoracic oncology, why he chose to focus on Alk+ Non- Small Cell Cancer and lung cancer trends Australia.

Dr. Ramon Rami Porta, Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa (Barcelona), Spain, joins Dr. Jack West for a discussion on the importance of lung cancer tumor staging, the status of CT Screening for lung cancer prevention in Europe and a preview of the IASLC World Conference on Lung Cancer in Barcelona. Listen to the end to get some...

Dr. Jack West is joined by Dr. Christine Lovly to discuss highlights from the 2019 ASCO Annual Meeting. Dr. Lovly is associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee.

Dr. Jack west is joined by Dr. Alex Adjei, Professor of Medicine, Professor of Medical Oncology and Editor-in-Chief at the Journal of Thoracic Oncology. Dr. West and Dr. Adjei discuss the evolution of the Journal of Thoracic Oncology and the impact it has on lung cancer awareness for professionals.

Dr. Jack West is joined by Dr. Alexander Drilon to discuss the challenge of NGS testing and increased participation and funding in lung cancer clinical trials. Dr. Drilon is Associate Attending Physician and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Drilon has been at the forefront of development of many novel targeted therap...

Dr. Jack West is joined by Dr. Anne Tsao for a conversation on the state of treatment of mesothelioma in anticipation of the first IASLC 2019 Mesothelioma Meeting July 10-12, 2019 in New York, NY. Dr. Tsao is Professor in the Department of Thoracic Head and Neck Medical Oncology in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston. She is also Director...

Dr. Jack West is joined by Dr. Corey Langer to discuss lung cancer management, niche patients including PS2 and elderly patients, the evolution of small cell lung cancer treatment and care, and chemo immunotherapy. Dr. Langer is Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania in Philadelphia.

Dr. Jack West is joined by Dr. Walter J. Curran for discussions on radiation oncology, immunotherapy and the interaction with radiation, and the evolution of proton therapy including growth of the field and access to treatment. Dr. Curran is Executive director of the Winship Cancer Institute of Emory University and current chair of the NRG Oncology Group.

Dr. Jack West is joined by Dr. David Spigel to discuss medication for lung cancer treatment, checkpoint inhibitor therapy and the future of duration of treatment for lung cancer patients. Dr. Spigel is Chief Scientific Officer at Sarah Cannon Research Institute in Nashville, Tennessee. Dr. Spigel is a medical oncologist with a particular focus on thoracic oncology.

IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Pasi Janne, a translational thoracic medical oncologist at the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He is also the Director of the Lowe Center for Thoracic Oncology and the Director of the Belfer Center for Applied Cancer Science. Voting is available to active IASLC members and end...

IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. William Travis, Attending Thoracic Pathologist at Memorial Sloan Kettering Cancer Center in New York. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.

IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Heather Wakelee, Professor of Medicine, Oncology at Stanford University in Stanford, California. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.

Dr. Jack West is joined by Dr. David Gandara to discuss blood based testing for molecular interrogation, blood based assays for tumor mutational burden, and how the landscape of lung cancer and the IASLC have evolved. Dr. Gandara is Professor of Medicine and Senior Adviser to the Director of Medical Oncology at University of California Davis in Davis, CA and past president of the IASLC.

Dr. Jack West is joined by Dr. Joan Schiller to discuss new developments in the field of lung cancer, the results of the trial ECOG 1594, mentorship in oncology, and women's support and representation in the practice of lung cancer. Dr. Schiller is a medical oncologist with a focus on thoracic oncology, faculty of the University of Virginia and previous chair of the lung cancer committee for the E...

Dr. Jack West is joined by IASLC president Dr. Giorgio Scagliotti for discussions on strategic goals of the IASLC and the evolution of staging efforts, the evolution in treating non-squamous non-small cell lung cancer, the status of screening efforts in Europe, and how patients are playing an active role in the study of lung cancer.

Dr. Jack West is joined by Dr. Christine Hann and Dr. Stephen Liu for a discussion on the advancement of therapies in small cell lung cancer. Lung Cancer Considered is the podcast of the International Association for the Study of Lung Cancer (IASLC).